*By Bridgette Webb*
Drugmaker Merck announced earlier this month it will slash prices on several drugs by 10 percent or more.
But there is a catch: the price rollback will only affect some of the smaller products in its portfolioーlike Hepatitis C drug, Zepatier, which accounts for about 4 percent of the company's salesーand not top sellers like cancer treatment Keytruda.
"Their scope is relatively limited," said Peter Loftus, a Reporter for the Wall Street Journal, during an interview on Cheddar Monday. "If you think about the total sales that Merck generatesーit's a relatively small percentage."
Merck's announcement was met with praise from the Trump administration. Health and Human Services Secretary Alex Azar claimed the drop in prices was spurred by Trump's latest crackdown on pharmaceutical companies.
Other big pharma names are following suit: Pfizer and Novartis announced they will freeze price increases for the rest of the year, earning them congratulatory tweets from the president.
Despite all of the price freezes and drops, Loftus says that patients may not actually see any real savings.
"I don't think you can say on a widespread basis, and really for the average drug or patient, that prices are coming down, there are still price increases."
For the full segment, [click here.]
(https://cheddar.com/videos/drugmakers-tout-lower-prices)
HIV and AIDS have long had a disproportionate impact on the Black community. In recognition of that stark reality, the U.S. government marked February 7 as National Black HIV/AIDS Awareness Day.
New York dropped its vaccine requirement for city workers.
The Biden administration is set to boost the health standards of meals provided in public schools across the U.S.
The Food and Drug Administration still hasn't regulated the cannabis compound CBD — and the agency said it has no plans to.
World food prices fell in January for the 10th straight month, according to data.
An arctic blast is hitting the Northeast as millions are dealing with wind chills that could hit as low as 60 below zero.
Aerospace startup Atomos Space, which is developing a series of orbital transfer vehicles to help reposition satellites in space, recently closed on a $16 million financing round. CEO Vanessa Clark and COO William Kowalski joined Cheddar News to discuss the company's operations ahead of its launch.
Oatly has launched climate footprint labels on its products in North America.
British energy giant BP predicts that fossil fuels as a primary energy source will decline from 80 percent in 2019 to between 55 and 20 percent in 2050.
First responders fired after video of police beating Tyre Nichols was released, 10 people show in Lanland, Fla. and winter storm is causing travel troubles. Here is everything you Need2Know for January 31, 2023.
